Statistics for Targeted immunotherapy for HER2-low breast cancer with 17p loss
Total visits
| views | |
|---|---|
| Targeted immunotherapy for HER2-low breast cancer with 17p loss | 59 |
Total visits per month
| views | |
|---|---|
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| nihms-1724166.pdf | 155 |
| java.util.UUID:5450efe9-adee-4c24-a653-ee480172978d | 79 |
| java.util.UUID:fc23dddc-20d1-4b0b-ae74-22a88dcedf5e | 13 |
| java.util.UUID:bae0b83e-ad1f-47ed-8dc0-b0cdefeabad1 | 5 |
Top country views
| views | |
|---|---|
| United States | 50 |
| France | 2 |
| China | 1 |
| South Korea | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 42 |
| Ann Arbor | 3 |
| Cambridge | 2 |
| Paris | 2 |
| White Plains | 2 |
| Ashburn | 1 |
| Beijing | 1 |
| Seoul | 1 |